Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.5.4 has been added to the record history, replacing the previous v3.5.3. This reflects a minor update to the historical record rather than changes to the study data.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now lists Revision: v3.5.3, indicating an updated version of the study record metadata.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision v3.5.2 was added to the history and Revision v3.5.0 was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site; no user-visible content or data changes are indicated in the screenshot.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision history adds Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision: v3.4.2 was added to the history, and the older funding notice and revision v3.4.1 were removed.SummaryDifference0.8%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.